Dr. Jeffrey C. Rathmell
Dr. Rathmell studies mechanisms that influence lymphocyte death and differentiation in inflammatory diseases and cancer. Following undergraduate studies at the University of Northern Iowa, his earned a PhD in Immunology at Stanford University. In postdoctoral studies at the University of Chicago and University of Pennsylvania, he showed that lymphocyte metabolism was dynamically regulated to control cell function and survival in inflammatory diseases and cancer. He began at Duke University in 2003 in the departments of Pharmacology and Cancer Biology and Immunology and moved in 2015 to Vanderbilt University to direct the Vanderbilt Center for Immunobiology and co-leads to Host Tumor Interactions Program of the Vanderbilt Ingram Cancer Center. The ongoing focus on Dr. Rathmell’s ongoing work is to understand how metabolic pathways regulate CD4 T cell subsets in inflammatory diseases and how the tumor microenvironment and metabolism impacts anti-cancer responses.